Pharmarise Holdings Corporation (2796.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 5.49B |
| Enterprise Value | 14.88B |
| P/E Ratio | -53.45 |
| PEG Ratio | -0.2 |
| Price/Sales Ratio | 0.09 |
| Price/Book Ratio | 0.87 |
| Enterprise/Revenue | 0.27 |
| Enterprise/EBITDA | 7.99 |
Fiscal Year
| Fiscal Year | May 31, 2025 |
| Most Recent Quarter | February 28, 2026 |
Profitability
| Profit Margin | -0 |
| Operating Margin | 0.01 |
AD
Management Effectiveness
| Return On Assets | -0 |
| Return On Equity | -0.02 |
Income Statement
| Revenue | 63.51B |
| Revenue/Share | 5,866.97 |
| Gross Profit | 8.2B |
| EBITDA | 1.68B |
| Net Income | -368M |
| Diluted EPS | -32.42 |
Balance Sheet
| Total Cash | 2.24B |
| Total Cash/Share | 194.91 |
| Total Debt | 14.67B |
| Total Debt/Equity | 2.19 |
| Current Ratio | 0.93 |
| Book Value Per Share | 583.26 |
Price History
| 52-Week Change | 2.65 |
| 52-Week High | 567 |
| 52-Week Low | 487 |
| Moving Average 50 Days | 517.28 |
| Moving Average 200 Days | 519.91 |
Statistics
| Average Volume | 7,349 |
| Shares Outstanding | 11.5M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 14 |
| Trailing Annual Dividend Yield | 2.78 |
| Payout Ratio | 0 |
| Last Split Factor | 100:1 |
| Last Split Date | November 27, 2013 |
AD
